Peculiarities of Adverse Events Manifested by Injury of Skin and Skin Derivatives and Associated with Beta-blockers Use
More than 50 years after Propranolol was introduced to the pharmaceutical market as a drug that can lower the heart rate, beta-blockers (BAB) are still widely used in the pharmacotherapy of cardiovascular diseases. However, the use of BAB has a number of limitations, first of all, due to adverse dru...
Saved in:
Main Authors: | A. V. Matveev, E. A. Egorova, E. I. Konyaeva, A. G. Dormidor, E. Yu. Bekirova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2021-11-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2591 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01) -
PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES
by: S. Yu. Martsevich, et al.
Published: (2016-06-01) -
THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01) -
Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01) -
THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE
by: Yu. V. Lukina, et al.
Published: (2016-01-01)